Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Sell
18,185
-4,529
-20% -$523K 0.09% 284
2026
Q1
$2.71M Sell
22,714
-454
-2% -$59.5K 0.13% 237
2025
Q4
$3.16M Sell
23,168
-2,677
-10% -$385K 0.14% 217
2025
Q3
$3.81M Sell
25,845
-342
-1% -$47.4K 0.16% 172
2025
Q2
$3.39M Sell
26,187
-5,109
-16% -$619K 0.15% 199
2025
Q1
$3.74M Sell
31,296
-5,741
-16% -$711K 0.17% 186
2024
Q4
$4.3M Buy
+37,037
New +$4.68M 0.17% 166

Other funds holding XYL

New Age Alpha Advisors's XYL Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Xylem (XYL) stake by 20% in Q2 2026, selling an estimated $523K and leaving 18,185 shares worth $2.15M. The position accounts for 0.09% of the portfolio, ranked #284.

New Age Alpha Advisors first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.3M in Q4 2024. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • New Age Alpha Advisors held 18,185 shares of Xylem worth $2.15M as of Q2 2026.
  • New Age Alpha Advisors sold 4,529 Xylem shares in Q2 2026, an estimated $523K.
  • Xylem made up 0.09% of New Age Alpha Advisors's portfolio in Q2 2026, its #284 holding.
  • New Age Alpha Advisors first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Xylem position peaked at $4.3M in Q4 2024.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.